Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
01-2002 | 10-2001 | 07-2001 | 04-2001 | 01-2001 | |
Sales | 293,500 | 391,600 | 547,500 | 652,400 | 811,300 |
Cost of Goods | 198,700 | 277,400 | 369,800 | 530,100 | 500,500 |
Gross Profit | 94,800 | 114,200 | 177,700 | 122,300 | 310,800 |
Operating Expenses | 160,900 | 340,200 | 277,000 | 816,600 | 324,300 |
Operating Income | -65,400 | -225,600 | -98,500 | -694,200 | -13,000 |
Other Income | -4,500 | -138,500 | 11,700 | -765,000 | 2,400 |
Pre-tax Income | -69,900 | -364,100 | -86,800 | -1,459,200 | -10,600 |
Income Tax | -25,100 | -187,300 | -28,700 | -414,000 | -3,000 |
Net Income Continuous | -44,800 | -176,800 | -58,100 | -1,045,200 | -7,600 |
Net Income | $-44,800 | $-176,800 | $-58,100 | $-1,045,200 | $-7,600 |
EPS Basic Total Ops | -0.42 | -1.61 | -0.49 | -9.31 | -0.07 |
EPS Basic Continuous Ops | -0.40 | -1.56 | -0.52 | -9.31 | -0.07 |
EPS Diluted Total Ops | -0.42 | -1.61 | -0.49 | -9.31 | -0.07 |
EPS Diluted Continuous Ops | -0.40 | -1.56 | -0.52 | -9.31 | -0.07 |
EBITDA(a) | $-157,400 | $-131,800 | $444,900 | $-638,500 | $-508,100 |